Catalyst Wire Dossier Catalyst Wire Dossier

Combivent (ipratropium bromide/albuterol)

ipratropium bromide and albuterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Combivent (ipratropium bromide/albuterol), covering 2009-06-01 to 2009-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

See pricing